| abstract |
A carborane-containing porphyrin of formula (1) is provided for use in cancer therapy to prolong the period between required doses while the patient is undergoing radiation therapy. The compound may be given no more than once every two weeks or longer, avoiding repeated administrations while radiation therapy may continue on a regular basis. |